Engaging youth and their caregivers in medication treatment for opioid use disorders-Recording

Video Transcription

Video Summary

In a recent presentation organized by the New England Region Opioid Response Network, discussions focused on engaging youth and caregivers in medication-assisted treatment for opioid use disorders. Led by Dr. Amy Ewell, a child and addiction psychiatrist, the session emphasized the significance of using medication to effectively treat opioid use disorders among youth. Dr. Ewell highlighted various medications approved for opioid use disorders, such as naltrexone, buprenorphine, and methadone, discussing their mechanisms of action and the importance of these treatments in reducing overdose risk.<br /><br />Dr. Ewell stressed the need for clear communication between healthcare providers, youth, and caregivers, explaining common misconceptions about these treatments. It was noted that building a supportive environment within families and ensuring adherence to medication are crucial for successful outcomes. The presentation also covered the importance of harm reduction practices and overdose prevention, advocating for the education of youth and caregivers on the risks of fentanyl-laced substances, the use of naloxone, and the significance of contacting emergency services during an overdose.<br /><br />The overarching message was the need for integrating medication into broader treatment plans while emphasizing flexibility to meet individual needs, ensuring youth receive comprehensive support for recovery.

Keywords

opioid use disorders

medication-assisted treatment

youth engagement

caregiver involvement

naltrexone

buprenorphine

methadone

harm reduction

overdose prevention